Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Hou (Taipei, Taiwan), H. Wang (Taipei, Taiwan), C. Yu (Taipei, Taiwan). MMP-12 activates protease activated receptor (PAR)-1, upregulates placenta growth factor and leads to pulmonary emphysema. 4257

Member's Comments

No comment yet.

Related content which might interest you: Jun kinase regulates the expression of TGF-beta induced connective tissue growth factor in human lung fibroblast Source: Annual Congress 2004 - Inflammation and remodelling in human lungs Year: 2004 The natural anticoagulant activated protein C inhibits the expression of platelet-derived growth factor in the lung Source: Eur Respir J 2002; 20: Suppl. 38, 571s Year: 2002 Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003 Pharmacological inhibition of epidermal growth factor receptor modulates cigarette smoke-induced CXCL8 release but not VEGF release Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 The protease activated receptor (PAR)-2/tissue factor/coagulation factor VIIa axis in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway Source: Eur Respir J 2008; 31: 523-531 Year: 2008 Bradykinin phosphorylates ERK1/2 through epidermal growth factor receptor transactivation in human lung fibroblasts Source: Eur Respir J 2005; 26: Suppl. 49, 341s Year: 2005 RB2/p130 gene-enhanced expression downregulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002 Attenuation of bleomycin-induced pulmonary fibrosis by direct thrombin inhibition is accompanied by a reduction in connective tissue growth factor mRNA levels Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 Epidermal growth factor receptor (EGFR) overexpression in human bronchial epithelial cells amplifies IL-8 release provoked by cigarette smoke and bacterial surrogates Source: Eur Respir J 2005; 26: Suppl. 49, 441s Year: 2005 LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Haemophilus influenzae (NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 PP216 – Glucocorticoids exacerbate TGFß1 mediated fibrotic signalling in lung fibroblasts by inhibition of metalloproteinase expression and activity Source: ERS Lung Science Conference 2021 Year: 2021 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010